Prazosin Hydrochloride — CAS 19237-84-4

Prazosin Hydrochloride is a selective alpha-1 adrenergic receptor antagonist used primarily in the treatment of hypertension. It also finds use in benign prostatic hyperplasia and PTSD-associated nightmares. The HCl salt form provides improved water solubility for pharmaceutical formulations. Mediocon Inc manufactures Prazosin Hydrochloride API at its GMP-certified facility in Aurangabad, Maharashtra, India.

• Management of hypertension (high blood pressure)
• Treatment of benign prostatic hyperplasia (BPH) to improve urinary flow
• Management of PTSD-related nightmares and sleep disturbances
• Off-label use in Raynaud's syndrome and scorpion sting management

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support